Unic-StojanovicDIsenovicERJovicM. Copeptin levels do not correlate with cross clamping time in patients undergoing carotid endarterectomy under general anesthesia. Angiology. 2016;67(10):951–960.
2.
WestermannIDunserMWHaasT. Endogenous vasopressin and copeptin response in multiple trauma patients. Stroke. 2007;28(6):644–649.
3.
JochbergerSDorlerJLucknerG. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med. 2009;37(2):476–482.
4.
DobsaLEdozienKC. Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochem Med (Zagreb). 2013;23(2):172–190.
5.
ChoiKSKimHJChunHJ. Prognostic role of copeptin after stroke: a systematic review and meta-analysis of observational studies. Sci Rep. 2015;5:11665.
6.
TamargoRJ. Copeptin in aneurysmal subarachnoid hemorrhage. Crit Care. 2012;16(1):103.
7.
KhanSQDhillonOSO’BrienRJ. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007;115(16):2103–2110.
8.
StoiserBMörtlDHülsmannM. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest. 2006;36(11):771–778.
9.
UrwylerSASchuetzPFluriF. Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke. 2010;41(7):1564–1567.
10.
KatanMFluriFMorgenthalerNG. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol. 2009;66(6):799–808.
GreiseneggerSSegalHCBurgessAIPooleDLMehtaZRothwellPM. Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study. Stroke. 2015;46(11):3117–3123.
13.
JaraiRMahlaEPerkmannT. Usefulness of pre-operative copeptin concentrations to predict post-operative outcome after major vascular surgery. Am J Cardiol. 2011;108(8):1188–1195.
14.
RadakDResanovicIIsenovicER. Link between oxidative stress and acute brain ischemia. Angiology. 2014;65(8):667–676.
15.
RadakDResanovicIIsenovicER. Changes in hypothalamus-pituitary-adrenal axis following transient ischemic attack. Angiology. 2014;65(8):723–732.
16.
MorgenthalerNGStuckJAlonsoCBergmannA. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112–119.
17.
Maravic-StojkovicVLausevic-VukLJObradovicM. Copeptin levels after carotid endarterectomy and perioperative stroke. Angiology. 2014;65(2):122–129.
18.
SchlapbachLJFreySBiglerS. Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia. BMC Pediatr. 2011;11:38.
19.
BenzingJWellmannSAchiniF. Plasma copeptin in preterm infants: a highly sensitive marker of fetal and neonatal stress. J Clin Endocrinol Metab. 2011;96(6):e982–e985.
20.
SaleemUKhaleghiMMorgenthalerNG. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab. 2009;94(7):2558–2564.
21.
EnhorningSWangTJNilssonPM. Plasma copeptin and the risk of diabetes mellitus. Circulation. 2010;121(19):2102–2108.
22.
EnhorningSBankirLBoubyN. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmo Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond). 2013;37(4):598–603.
23.
BrianaDDBakaSBoutsikouM. Cord blood copeptin concentrations in fetal macrosomia. Metabolism. 2016;65(1):89–94.
24.
BulbulGAKumruSErolO. Maternal and umbilical cord copeptin levels in pregnancies complicated by fetal growth restriction. J Matern Fetal Neonatal Med. 2014:1–7.
25.
HalesCNBarkerDJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.
26.
BarkerDJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;95(2):115–128.
27.
BenzingJWellmannSAchiniF. Plasma copeptin in preterm infants: a highly sensitive marker of fetal and neonatal stress. J Clin Endocrinol Metab. 2011;96(6):e982–e985.
